The global burden of antimicrobial resistance – urinary tract infections

  01 November 2023

The risk for AMR in UTI varies in different patient populations. History of antibiotic consumption and physiology of urinary flow are major factors that shape AMR prevalence. The urinary tract is in close crosstalk with the microbiome of other compartments, such as the gut or the genital tracts. In addition, pharmacokinetic properties and the physiochemical composition of urinary compartments can contribute to emergence of AMR. Alternatives to antibiotic treatment and a broader approach to address bacterial infections are needed. Among the various alternatives studied, antimicrobial peptides (AMPs) and bacteriophage treatment appear to be highly promising approaches. We here summarize the present knowledge of clinical and microbiological AMR in UTI and discuss innovative approaches, namely new risk prediction tools and the use of non-antibiotic approaches to defend against uropathogenic microbes.

Further reading: Nephrol Dial Transplant
Author(s): Sibylle Von Vietinghoff et al
Effective Surveillance  


Unrestricted financial support by:


Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre


Ambassador Network

Join the AMR Insights Ambassador Network today!

Connect to over 550 AMR professionals and students in 60 countries!

More information
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!
WordPress PopUp Plugin